- Home
- LSTA vs SLGL Comparison
LSTA vs SLGL Comparison
Compare LSTA & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- SLGL
- Stock Information
- Founded
- LSTA 1980
- SLGL 1997
- Country
- LSTA United States
- SLGL Israel
- Employees
- LSTA N/A
- SLGL N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- LSTA Health Care
- SLGL Health Care
- Exchange
- LSTA Nasdaq
- SLGL Nasdaq
- Market Cap
- LSTA 31.2M
- SLGL 30.9M
- IPO Year
- LSTA N/A
- SLGL 2018
- Fundamental
- Price
- LSTA $3.71
- SLGL $1.05
- Analyst Decision
- LSTA Strong Buy
- SLGL Strong Buy
- Analyst Count
- LSTA 1
- SLGL 2
- Target Price
- LSTA $15.00
- SLGL $5.00
- AVG Volume (30 Days)
- LSTA 53.5K
- SLGL 1.5M
- Earning Date
- LSTA 02-27-2025
- SLGL 03-12-2025
- Dividend Yield
- LSTA N/A
- SLGL N/A
- EPS Growth
- LSTA N/A
- SLGL N/A
- EPS
- LSTA N/A
- SLGL N/A
- Revenue
- LSTA N/A
- SLGL $11,707,000.00
- Revenue This Year
- LSTA N/A
- SLGL $500.51
- Revenue Next Year
- LSTA N/A
- SLGL N/A
- P/E Ratio
- LSTA N/A
- SLGL N/A
- Revenue Growth
- LSTA N/A
- SLGL 869.93
- 52 Week Low
- LSTA $2.19
- SLGL $0.33
- 52 Week High
- LSTA $4.20
- SLGL $1.65
- Technical
- Relative Strength Index (RSI)
- LSTA 66.07
- SLGL 52.10
- Support Level
- LSTA $3.52
- SLGL $1.11
- Resistance Level
- LSTA $3.87
- SLGL $1.40
- Average True Range (ATR)
- LSTA 0.29
- SLGL 0.21
- MACD
- LSTA 0.02
- SLGL -0.01
- Stochastic Oscillator
- LSTA 63.97
- SLGL 21.05
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.